FunPep Company Limited (4881.T)
JPY 101.0
(2.02%)
JPY 101.0
(2.02%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -994 Million JPY | 14.97% |
| 2022 | -1.16 Billion JPY | -56.91% |
| 2021 | -745.04 Million JPY | -31.96% |
| 2020 | -564.59 Million JPY | -97.59% |
| 2019 | -285.73 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -183.52 Million JPY | 2.47% |
| 2024 Q2 | -212.02 Million JPY | -15.53% |
| 2023 Q2 | -243.83 Million JPY | 35.62% |
| 2023 Q4 | -188.16 Million JPY | -2.62% |
| 2023 Q1 | -378.75 Million JPY | -6.01% |
| 2023 FY | -994.1 Million JPY | 14.97% |
| 2023 Q3 | -183.35 Million JPY | 24.8% |
| 2022 Q3 | -296.65 Million JPY | 0.0% |
| 2022 FY | -1.16 Billion JPY | -56.91% |
| 2022 Q4 | -357.27 Million JPY | -20.43% |
| 2021 FY | -745.04 Million JPY | -31.96% |
| 2020 FY | -564.59 Million JPY | -97.59% |
| 2019 FY | -285.73 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 266.549% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -100.053% |
| GNI Group Ltd. | 13.1 Billion JPY | 107.583% |
| Linical Co., Ltd. | 725.72 Million JPY | 236.967% |
| Trans Genic Inc. | 89.43 Million JPY | 1211.409% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 30.292% |
| Soiken Holdings Inc. | -610 Million JPY | -62.949% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -28.633% |
| AnGes, Inc. | -11.96 Billion JPY | 91.694% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 11.313% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 89.565% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 1053.029% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | -14.991% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 11.01% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 21.236% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -24.474% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -194.636% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 17.522% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 25.576% |
| PeptiDream Inc. | 6.77 Billion JPY | 114.676% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 48.497% |
| Ribomic Inc. | -1.11 Billion JPY | 10.947% |
| SanBio Company Limited | -4.53 Billion JPY | 78.101% |
| Healios K.K. | -3.37 Billion JPY | 70.583% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 13.945% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 28.669% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 29.152% |
| StemRIM | -2.07 Billion JPY | 52.119% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 181.375% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -11.841% |
| Stella Pharma Corporation | -760.3 Million JPY | -30.738% |
| TMS Co., Ltd. | -943.25 Million JPY | -5.38% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -28.193% |
| Cuorips Inc. | -588.48 Million JPY | -68.908% |
| K Pharma,Inc. | 366.05 Million JPY | 371.542% |
| Takara Bio Inc. | 3 Billion JPY | 133.1% |
| ReproCELL Incorporated | -409.29 Million JPY | -142.858% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 9084.905% |
| StemCell Institute Inc. | 413.75 Million JPY | 340.236% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 787.856% |
| CellSeed Inc. | -697.77 Million JPY | -42.453% |